Emergent Biosolutions (EBS)Officer sold ~$20K

~$20K

Approx. value · 3,000 sh @ $6.53

156K

Holds after · shares reported

Traded

Oct 1, 2026

Filed

Oct 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 5, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and changed a top executive or board member (and 2 more items)“In connection with the actions described above, on August 5, 2026 the Company also announced that it will eliminate the role of Chief Medical Officer, Head of Research and Development.”
2. Oct 1, 2026 · this disclosureInsiderOfficer sold ~$20K of EBS shares in the open market

What came next

1. Oct 7, 2026InsiderDirector sold ~$126K of EBS shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Emergent Biosolutions

For Emergent Biosolutions, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EBS page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Emergent Biosolutions

• SEC Form 144Oct 7, 2026
• SEC Form 4Oct 7, 2026
• USAspending.gov award recordJun 4, 2026
• USAspending.gov award recordApr 28, 2026
• USAspending.gov award recordMar 4, 2026
• SEC Form 4Aug 18, 2025

Everything OQRO holds on this company is on its EBS page.